Skip to content

13F-HR/A filed by FARALLON CAPITAL MANAGEMENT, L.L.C.

FARALLON CAPITAL MANAGEMENT, L.L.C. filed this 13F-HR/A for the quarter ended 2020-12-31, filed 2021-08-13, with 2 holding rows worth $558,552,000.

Accession
0000950123-21-010860
Filed
2021-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, amendment of type new holdings, 2 entries on the cover page, a total value of $558,552,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $558,552,000 with VALUE read as thousands by filing date, 13F file number 028-03896. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALEXION PHARMACEUTICALS INC015351109COM2,246,900$351,056,000thousands by filing date
SLACK TECHNOLOGIES INC83088V102COM CL A4,912,300$207,496,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-21-001814 base2021-02-16acceptance time not in the bulk data set
13F-HR/A 0000950123-21-006782 added2021-05-17acceptance time not in the bulk data set
13F-HR/A 0000950123-21-010860this filing2021-08-13acceptance time not in the bulk data set
13F-HR/A 0000950123-21-015177 added2021-11-15acceptance time not in the bulk data set
13F-HR/A 0001567619-22-010741 added2022-05-16acceptance time not in the bulk data set